MARKET

SILK

SILK

Silk Road Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

45.44
-1.52
-3.23%
Opening 09:38 02/24 EST
OPEN
45.70
PREV CLOSE
46.95
HIGH
45.81
LOW
45.15
VOLUME
8.62K
TURNOVER
--
52 WEEK HIGH
51.50
52 WEEK LOW
27.83
MARKET CAP
1.30B
P/E (TTM)
-23.1210
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SILK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SILK stock price target is 49.33 with a high estimate of 51.00 and a low estimate of 48.00.

EPS

SILK News

More
  • The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
  • Benzinga · 15h ago
  • Silk Road Medical to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020
  • GlobeNewswire · 02/13 21:05
  • Is Silk Road Medical a Buy?
  • MotleyFool.com · 02/06 16:26
  • Silk Energy Announces Closing of Private Placement of Convertible Debentures and Corrects Prior News Release
  • Newsfile · 01/30 21:28

Industry

Medical Equipment, Supplies & Distribution
-2.10%
Healthcare Equipment & Supplies
-2.41%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About SILK

Silk Road Medical, Inc. is a medical device company. The Company has developed an approach for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). The Company’s TCAR relies on two concepts - minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines the benefits of endovascular techniques with fundamental surgical principles. The Company’s ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. The ENROUTE Transcarotid Stent is indicated for use in High Surgical Risk patients and is designed to be used in conjunction with the ENROUTE NPS during the TCAR procedure. The ENROUTE Transcarotid NPS is a device used to access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.
More

Webull offers kinds of Silk Road Medical Inc stock information, including NASDAQ:SILK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILK stock news, and many more online research tools to help you make informed decisions.